[Pharmacologic basis for the treatment with anabolic steroids].
D045930:Anabolic Agents / Q000494:pharmacology*; D000818:Animals; D001842:Bone and Bones / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D004702:Endocrine Glands / Q000187:drug effects; D005032:Ethylestrenol / Q000494:pharmacology; D005474:Fluoxymesterone / Q000494:pharmacology; D050723:Fractures, Bone / Q000378:metabolism; D006168:Guinea Pigs; D006413:Hematopoietic System / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008710:Methenolone / Q000494:pharmacology; D012157:Mononuclear Phagocyte System / Q000187:drug effects; D009277:Nandrolone / Q000494:pharmacology; D010110:Oxymetholone / Q000494:pharmacology; D013739:Testosterone / Q000494:pharmacology
D045930:Anabolic Agents; D013739:Testosterone; D009277:Nandrolone; D008710:Methenolone; D005474:Fluoxymesterone; D005032:Ethylestrenol; D010110:Oxymetholone
Basi farmacologiche dei trattamenti con steroidi anabolizzanti.